Article Details
Retrieved on: 2018-04-28 18:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>April 29, 2018 - By Kurt Siggers. <b>Vanguard Group</b> Inc increased its stake in Fate Therapeutics Inc (FATE) by 13.73% based on its latest 2017Q4 regulatory filing with the SEC. <b>Vanguard Group</b> Inc bought 176,143 shares as the company's stock rose 82.53% while stock markets declined. The institutional ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here